Trailing-twelve-month (TTM) revenue is $3.84 Billion with a year-over-year growth of +58.91%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $956,048,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-10 |
| Q4 FY2025Period ended 2025-12-31 | $950,526,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-12 |
| Q1 FY2026Period ended 2026-03-31 | $965,100,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-08 |
| Q2 FY2026Period ended 2026-06-30 | $972,520,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-10 |
| TTM revenue | $3,844,194,000 |
Current P/S: $1,834,834,383 market capitalization ÷ $3,844,194,000 TTM revenue = 0.48x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T14:15:12.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $972.52M.
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 17 comparable quarters.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T14:15:45.702Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|
| Health Care Capitation Revenue | $1.9B | $2.9B |
| Health Care, Other | $86M | $86M |
| Health Care, Patient Service | $62M | $113M |
| Management Service | $14M | $30M |
| Product and Service, Other | $15M | $28M |
$3.84B
$3.84 Billion
+58.91%
vs. $2.42B a year ago (TTM)
+53.77%
5 Year compound annual growth rate
1 Year
+58.91%
3 Year
+43.64%
5 Year
+53.77%
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $3.18B | +$1.15B | +56.39% |
| 2024 | $2.03B | +$647.88M | +46.72% |
| 2023 | $1.39B | +$242.50M | +21.19% |
| 2022 | $1.14B | +$370.25M | +47.84% |
| 2021 | $773.91M | +$403.67M | +109.03% |
| 2020 |
TTM Growth
+58.91%
3-Year CAGR
+43.64%
5-Year CAGR
+53.77%
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T14:15:45.702Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $370.25M |
| ($190.37M) |
| (33.96%) |
| 2019 | $560.62M | +$40.71M | +7.83% |
| 2018 | $519.91M | +$162.16M | +45.33% |
| 2017 | $357.75M | +$313.70M | +712.16% |
